| Prognostic value and clinical feature of SF3B1 mutations in myelodysplastic syndromes: A meta-analysis. |
|
Crit Rev Oncol Hematol |
Myelodysplastic Syndromes (MDS) |
| Retuning the immune system in myelodysplastic syndromes: from immunomodulatory approaches to vaccination strategies and non myeloablative hemopoietic cell transplant. |
|
Crit Rev Oncol Hematol |
Myelodysplastic Syndromes (MDS) |
| Detection of paroxysmal nocturnal hemoglobinuria (PNH) in bone marrow aspirates |
|
Semin Hematol |
Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Effectiveness of eculizumab in patients with paroxysmal nocturnal hemoglobinuria (PNH) with or without aplastic anemia in the International PNH Registry |
|
Am J Hematol |
Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Consider Allogeneic Bone Marrow Transplantation for Older, Fit Patients with Aplastic Anemia |
|
Biol Blood Marrow Transplant |
Aplastic Anemia |
| TP53 mutation status divides myelodysplastic syndromes with complex karyotypes into distinct prognostic subgroups. |
|
Leukemia |
Myelodysplastic Syndromes (MDS) |
| Calculator-free point-of-care prognostication in myelodysplastic syndromes. |
|
Am J Hematol |
Myelodysplastic Syndromes (MDS) |
| Treatment sequence of lenalidomide and hypomethylating agents and the impact on clinical outcomes for patients with myelodysplastic syndromes. |
|
Leuk Lymphoma. |
Myelodysplastic Syndromes (MDS) |
| Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes. |
|
Bone Marrow Transplant |
Myelodysplastic Syndromes (MDS) |
| Immunosuppressive therapy versus haploidentical transplantation in adults with acquired severe aplastic anemia |
|
Bone Marrow Transplant |
Aplastic Anemia |
